Immunity of unloaded dendritic cells in lung melanoma of mice

Abstract

In order to investigate the immunity of unloaded dendritic cells (DCs) derived from murine bone marrow to preexisting lung melanoma metastases of mice, MO5 were intravenously injected to induce lung metastases in syngeneic C57BL/6 mice. Unloaded GM-CSF DCs, PBS and DCs+SIINFEKEL were subcutaneously injected into the mice, which were divided as experimental group, negative control group and positive control group respectively. Monoclonal antibody was used to deplete NK or T cells separately. The immunity-inhibitory effects on the lung melanoma were observed and the corresponding effector cells were examined. It was found that in the experimental and positive groups, the regression was induced in metastatic nodules in the lungs of tumor-bearing mice, but abrogated by treatment with anti-asialo-GM1 but not anti-CD8. It was concluded that the unloaded DCs could suppress the lung melanoma metastases to some extent, which was mediated by NK cells, and could be used as a potent therapeutic agents for lung tumor.

Keywords

dendritic cell / NK cell / lung tumor / immunity

References

[1] JeffordM., MaraskovskyE., CebonJ., et al.. The use of dendritic cells in cancer therapy. Lancet Oncol, 2001, 2(6): 343-353

[2] Rodriguez-LecompteJ. C., KruthS., GyorffyS., et al.. Cell-based cancer gene therapy: breaking tolerance or inducing autoimmunity?. Anim Health Res Rev, 2004, 5(2): 227-234

[3] SureshK., FraserG., ScheidE., et al.. Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate. Leuk Lymphoma, 2006, 47(2): 297-306

[4] LanierL.. On guard-activating NK cell receptors. Nat Immunol, 2001, 2(1): 23-27

[5] LutzM. B., KukutschA., OgilvieS., et al.. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods, 1999, 223(1): 77-92

[6] Van den BroekeL. T., DaschbachE., ThomasE. K., et al.. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol, 2003, 171(11): 5842-5852

[7] PawlowskaA. B., HashinoS., McKennaH., et al.. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice. Blood, 2001, 97(5): 1474-1482

[8] AdamC., KingS., AllgeierT., et al.. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood, 2005, 106(1): 338-344